T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$1.23B |
| 2 |
Service Corp International
SCI
|
+$639M |
| 3 |
NXP Semiconductors
NXPI
|
+$628M |
| 4 |
Advanced Micro Devices
AMD
|
+$623M |
| 5 |
NVIDIA
NVDA
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCN
Waste Connections
WCN
|
+$1.13B |
| 2 |
Exelon
EXC
|
+$799M |
| 3 |
Veralto
VLTO
|
+$730M |
| 4 |
Intuit
INTU
|
+$728M |
| 5 |
Intercontinental Exchange
ICE
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.23% |
| 2 | Healthcare | 21.6% |
| 3 | Consumer Discretionary | 13.06% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Reddit
RDDT
$29.8B
| $267M | 0.16% |
4,049,268
+2,402,200
| +146% | +$149M |
|
152
Ascendis Pharma A/S
ASND
$16.2B
| $264M | 0.16% |
1,765,042
+1,734,478
| +5,675% | +$234M |
|
|
THS
153
DELISTED
Treehouse Foods
THS
| $257M | 0.16% |
6,125,550
-1,254,024
| -17% | -$49.8M |
|
154
FirstService
FSV
$6.19B
| $257M | 0.15% |
1,407,893
-178,420
| -11% | -$30.7M |
|
|
155
Exelon
EXC
$47B
| $256M | 0.15% |
6,313,261
-21,253,751
| -77% | -$799M |
|
156
Constellium
CSTM
$3.94B
| $254M | 0.15% |
15,646,915
+1,625,657
| +12% | +$27.6M |
|
157
West Pharmaceutical
WST
$24.5B
| $252M | 0.15% |
839,310
-282,675
| -25% | -$86.6M |
|
158
Reynolds Consumer Products
REYN
$5.57B
| $250M | 0.15% |
8,048,368
-72,540
| -0.9% | -$2.15M |
|
159
McCormick & Company Non-Voting
MKC
$14.5B
| $249M | 0.15% |
3,024,174
+129,745
| +4% | +$10.1M |
|
160
Cognex
CGNX
$10.2B
| $249M | 0.15% |
6,137,424
-64,541
| -1% | -$2.75M |
|
161
Oscar Health
OSCR
$9.4B
| $247M | 0.15% |
11,661,066
+375,471
| +3% | +$6.76M |
|
162
Quanta Services
PWR
$101B
| $244M | 0.15% |
817,390
-5,500
| -0.7% | -$1.45M |
|
163
Sarepta Therapeutics
SRPT
$1.94B
| $243M | 0.15% |
1,946,240
-12,395
| -0.6% | -$1.71M |
|
164
Markel Group
MKL
$22.9B
| $243M | 0.15% |
154,720
+660
| +0.4% | +$1.03M |
|
165
Texas Capital Bancshares
TCBI
$4.41B
| $234M | 0.14% |
3,277,403
+382,171
| +13% | +$25M |
|
|
EXAS
166
DELISTED
Exact Sciences
EXAS
| $231M | 0.14% |
3,392,838
+451,636
| +15% | +$25.5M |
|
167
Popular Inc
BPOP
$11.3B
| $230M | 0.14% |
2,292,719
-329,162
| -13% | -$32.1M |
|
168
Haemonetics
HAE
$4.15B
| $229M | 0.14% |
2,850,637
+1,207,696
| +74% | +$97.6M |
|
169
SiteOne Landscape Supply
SITE
$4.22B
| $227M | 0.14% |
1,506,286
+337,648
| +29% | +$46.3M |
|
170
Home BancShares
HOMB
$6.27B
| $226M | 0.14% |
8,360,690
+77,073
| +0.9% | +$2.05M |
|
171
Magnolia Oil & Gas
MGY
$6.13B
| $226M | 0.14% |
9,266,621
-493,005
| -5% | -$12.4M |
|
172
Houlihan Lokey
HLI
$8.66B
| $224M | 0.14% |
1,419,908
-11,129
| -0.8% | -$1.66M |
|
173
Strategic Education
STRA
$1.83B
| $223M | 0.13% |
2,413,089
-163,940
| -6% | -$16.6M |
|
174
Mirion Technologies
MIR
$3.79B
| $223M | 0.13% |
20,171,888
+190,277
| +1% | +$2M |
|
175
Matador Resources
MTDR
$6.4B
| $221M | 0.13% |
4,463,029
-321,873
| -7% | -$18.1M |
|
Similar funds
T. Rowe Price Investment Management's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Investment Management held 663 positions worth $166B, up 4.7% from $158B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q3 2024 filing shows 43 new, 263 increased, 315 reduced and 41 closed positions. Its largest new stake was Willis Towers Watson: 1,570,828 shares worth $463M. The largest sale was Waste Connections, an estimated $1.13B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q3 2024 buy was Willis Towers Watson: 1,570,828 shares worth $463M.
- T. Rowe Price Investment Management added most to McKesson in Q3 2024, an estimated $1.23B increase.
- T. Rowe Price Investment Management's biggest Q3 2024 reduction was Waste Connections, cutting an estimated $1.13B.
- T. Rowe Price Investment Management fully exited Coterra Energy in Q3 2024, selling an estimated $313M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $166B portfolio in Q3 2024.
- T. Rowe Price Investment Management opened 43 new positions and closed 41 in Q3 2024.
- T. Rowe Price Investment Management's portfolio value rose 4.7% quarter-over-quarter to $166B.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.